SR 57227A
Alternative Names: SR 57227Latest Information Update: 22 Aug 1997
At a glance
- Originator Sanofi-Synthelabo
- Class Antidepressants
- Mechanism of Action Serotonin 3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder